Notice2023-09862

National Heart, Lung, and Blood Institute; Notice of Meetings

Primary source

Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.

Published
May 9, 2023

Issuing agencies

Health and Human Services DepartmentNational Institutes of Health

Full Text

<html>
<head>
<title>Federal Register, Volume 88 Issue 89 (Tuesday, May 9, 2023)</title>
</head>
<body><pre>
[Federal Register Volume 88, Number 89 (Tuesday, May 9, 2023)]
[Notices]
[Pages 29914-29915]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2023-09862]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Heart, Lung, and Blood Institute; Notice of Meetings

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    This will be a hybrid meeting held in-person and virtually and will 
be open to the public as indicated below.

[[Page 29915]]

Individuals who plan to attend and need special assistance, such as 
sign language interpretation or other reasonable accommodations, should 
notify the Contact Person listed below in advance of the meeting. The 
open session will be videocast and can be accessed from the NIH 
Videocast website https:/www.nhlbi.nih.gov/about/advisory-and-peer-
review-committees/advisory-council.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Heart, Lung, and Blood Advisory 
Council.
    Date: June 6, 2023.
    Closed: 9:00 a.m. to 10:00 p.m.
    Agenda: To Review and Evaluate Grant Applications.
    Place: National Institutes of Health, NHLBI, Rockledge I, 6705 
Rockledge Drive, Bethesda, MD 20892 (Hybrid Meeting).
    Open: 10:00 p.m. to 5:00 p.m.
    Agenda: To Discuss Program Policies and Issues.
    Place: National Institutes of Health, NHLBI, Rockledge I, 6705 
Rockledge Drive, Bethesda, MD 20892 (Hybrid Meeting).
    Virtual Access: The meeting will be videocast and can be 
accessed from the NIH Videocast. <a href="https://www.nhlbi.nih.gov/about/advisory-and-peer-review-committees/advisory-council">https://www.nhlbi.nih.gov/about/advisory-and-peer-review-committees/advisory-council</a>. Please note, 
the link to the videocast meeting will be posted within a week of 
the meeting date.
    Contact Person: Laura K. Moen, Ph.D., Director, Division of 
Extramural Research Activities, National Heart, Lung, and Blood 
Institute, National Institutes of Health, 6705 Rockledge Drive, Room 
206-Q, Bethesda, MD 20892, 301-827-5517, <a href="/cdn-cgi/l/email-protection#bcd1d3d9d2d0fcd1ddd5d092d2d5d492dbd3ca"><span class="__cf_email__" data-cfemail="610c0e040f0d210c00080d4f0f08094f060e17">[email&#160;protected]</span></a>.

    Any member of the public interested in presenting oral comments 
to the committee may notify the Contact Person listed on this notice 
at least 10 days in advance of the meeting. Interested individuals 
and representatives of organizations may submit a letter of intent, 
a brief description of the organization represented, and a short 
description of the oral presentation. Only one representative of an 
organization may be allowed to present oral comments and if accepted 
by the committee, presentations may be limited to five minutes. Both 
printed and electronic copies are requested for the record. In 
addition, any interested person may file written comments with the 
committee by forwarding their statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.
    In the interest of security, NIH has procedures at <a href="https://www.nih.gov/about-nih/visitor-information/campus-access-security">https://www.nih.gov/about-nih/visitor-information/campus-access-security</a> for 
entrance into on-campus and off-campus facilities. All visitor 
vehicles, including taxicabs, hotel, and airport shuttles will be 
inspected before being allowed on campus. Visitors attending a 
meeting on campus or at an off-campus federal facility will be asked 
to show one form of identification (for example, a government-issued 
photo ID, driver's license, or passport) and to state the purpose of 
their visit.
    Information is also available on the Institute's/Center's home 
page: <a href="http://www.nhlbi.nih.gov/meetings/nhlbac/index.htm">www.nhlbi.nih.gov/meetings/nhlbac/index.htm</a>, where an agenda 
and any additional information for the meeting will be posted when 
available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.233, 
National Center for Sleep Disorders Research; 93.837, Heart and 
Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, 
Blood Diseases and Resources Research, National Institutes of 
Health, HHS)

    Dated: May 4, 2023.
David W. Freeman,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2023-09862 Filed 5-8-23; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
Indexed from Federal Register on May 9, 2023.

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.